ACEIs or ARBs may lower risk of mortality in oesophagal and gastric cancer patients Dr. Shravani Dali3 May 2022 3:30 PM GMTPostdiagnosis use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) is associated with a lower risk for...
Mineralocorticoid Receptor Antagonists offer great economic value in HF patients: AHA/ACC/HFSA 2022. Dr. Prem Aggarwal28 April 2022 7:15 AM GMTMineralocorticoid Receptor Antagonists (MRA) have a great potential economic value to offer in patients with Heart Failure with mild ejection fraction...
Prolonged Exposure to ARB Linked with Cancer Risk MD Bureau7 March 2022 3:45 AM GMTAngiotensin-receptor blockers (ARBs) are a class of drugs approved for the treatment of several common conditions, such as hypertension and heart...
Telmisartan use reduces risk of dementia in hypertensive patients with Type 2- DM: Study Dr. Shravani Dali28 July 2021 6:15 AM GMTAdministering Telmisartan in type-2 diabetes patients with hypertension is linked with reduced risk of dementia and ischemic stroke, suggests a...
ARBs vs ACE Inhibitors as First-Line Treatment of hypertension: Study Hina Zahid27 July 2021 4:30 AM GMTYORK, NY - Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors are first line drugs for controlling high blood pressure.People...
Combination Therapy in Hypertension with Diabetes: Preferential Consideration for CCB and ARBs Dr. Pramila Kalra4 Jan 2021 7:15 AM GMTThe last edition of the International Diabetes Federation (IDF) Atlas offered projections that continue to put India at the second slot in the...
PARALLAX meets one primary endpoint in heart failure with preserved ejection fraction Hina Zahid8 Sep 2020 5:50 AM GMTSophia Antipolis, France - Sacubitril/valsartan reduces NT-proBNP, a biomarker predictive of long-term clinical outcomes in heart failure, but does...
Amlodipine and Cardiovascular outcomes in Hypertensive patients: What Meta-analysis says Dr. Prem Aggarwal17 Aug 2020 7:00 AM GMTA major risk factor for cardiovascular disease is hypertension. A multitude of drugs, including calcium channel blockers (CCBs), β-blockers,...
High BP drugs safe for patients with COVID-19 disease, finds Study Hina Zahid3 May 2020 8:15 AM GMTIn a study of 12,594 patients it has been found that common high blood pressure drugs did not increase the risk of contracting COVID-19 - or of...
ACEIs and ARBs may improve prognosis of high BP patients with COVID-19, finds review Dr. Kamal Kant Kohli31 March 2020 2:54 AM GMTRochester, MN, - Researchers after reviewing studies have concluded that ACEIs and ARBs, may have a role to play in the treatment of COVID-19 and may...
